Your trusted source for investing success
The biotech sector has steadily enjoyed an increase this year, in part thanks to significant advancements and in spite of the uncertainty from the White House as the proposal of a new healthcare bill holds the grip of most life science markets.
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
The medical device industry is robust and diverse. Here are four small medical device companies that investors should watch.
By Shelly Kumar
Gensource Potash Corporation (“Gensource” or the “Company”)(TSXV:GSP) is pleased to announce that it has entered into an engagement letter (“Engagement”) with a team of Industrial Alliance Securities Inc. (“IA”) and its syndication partner, US-based Heritage Capital Group (“Heritage”). Heritage is the Agriculture Practice Leader within the Oaklins Group, a close association
The Investing News reported took a closer look at some of the big cannabis news of the week and published an interview with the president of Cannabis Wheaton.
Cardiome saw significant decreases on both its stocks as a reaction to the decision from the FDA.
This past trading in the cannabis marketplace saw another major dip to the Marijuana Life Sciences Index, the first medical marijuana study funded by a US medical government research group.
As medical devices get technological advancements placing them into networks, the danger of threats to these crucial devices is growing as well. A new piece of legislation in the US Senate seeks to add mandated tests and better protections for remote access points.
Dynavax Technologies saw its stock jump over 70 percent on Monday thanks to a favorable review from the US Food and Drug Administration advisory committee for their hepatitis B vaccine.
By Jocelyn Aspa
Blockchain technology is set to ‘revolutionize’ the financial industry by growing to $30-$40 billion in trade finance by 2026.
By Melissa Shaw
Ucore Rare Metals (TSX VENTURE:UCU)(OTCQX:UURAF) (“Ucore” or the “Company”) is pleased to welcome the University of Kentucky to its recently announced US Rare Earths Consortium (the “Consortium”).
The Center for Applied Energy Research at the University of Kentucky (“UK CAER” or the “University”) joins Ucore and its partners in completing the
MYM Nutraceuticals Inc. (CSE:MYM) (OTC: MYMMF ) , is pleased to announce today that it has been made eligible for DTC electronic settlement and transfer of its common shares in the United States under the OTC symbol MYMMF.
This approval opens MYM up to the most important and influential investment market
The CEO of Canadian Bioceutical Corporation talks to us about their new acquisition and the opportunities for cannabis in Nevada.
Crescita Therapeutics signed an agreement with the Canadian subsidiary of Taro Pharmaceutical Industries for the rights to sell Pliaglis in the US.
Medical devices will facilitate the life of doctors and patients by providing cutting edge technology through simple to use gadgets or machinery, we take a look at what these companies achieve and go through.
The Investing News Network takes a look at some of the best-performing biotech stocks on the TSX during the first quarter of 2017.
Vodis Pharmaceuticals Inc. (CSE: VP / FSE: 1JV1) (“Vodis” or the “Company”) is pleased to announce it has closed a non-brokered private placement of 4,000,000 units (each, a “Unit”) of the Company at a price of $0.40 for total gross proceeds of $1,600,000. Each Unit will comprise one common share
By Pia Rivera
Vodis Pharmaceuticals Inc. (CSE:VP / FSE: 1JV1) (“Vodis” or the “Company”) is pleased to announce it has closed a non-brokered private placement of 4,000,000 units (each, a “Unit”) of the Company at a price of $0.40 for total gross proceeds of $1,600,000.
YDreams Global Interactive Technologies (TSXV:YD) has released a new project for Bob’s, one of the most traditional fast-food chains in Brazil, that recently celebrated its 65 anniversary alongside its franchisees by taking a dive into virtual reality. Bob’s, the Brazilian fast-food giant, created a concept store through Virtual and Augmented
Avita Medical is taking the steps to expand its skin treatment technology and enter the US market.
